Can economic evaluations be made more transferable?

@article{Boulenger2005CanEE,
  title={Can economic evaluations be made more transferable?},
  author={St{\'e}phanie Boulenger and John Nixon and Michael Drummond and Philippe Ulmann and Stephen Rice and G{\'e}rard de Pouvourville},
  journal={The European Journal of Health Economics},
  year={2005},
  volume={6},
  pages={334-346}
}
Several commentators have identified the lack of generalisability and transferability of economic evaluation results. The aims of this study were: (a) to develop a checklist to assess the level of generalisability and transferability of economic evaluations; (b) to assess the generalisability and transferability of economic evaluations between the UK and France using the checklist; (c) to identify reasons for any lack of transferability and generalisability; (d) to assess how the… CONTINUE READING

From This Paper

Figures, tables, results, connections, and topics extracted from this paper.
39 Extracted Citations
36 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 39 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 36 references

Vari abil i ty of cost-ef fec tiveness es ti mates for phar ma ceu ti cals in west ern Europe: lessons for in fer ring gen er al is abil i ty

  • M Bar bi eri
  • Health
  • 2005
Highly Influential
5 Excerpts

A de cision chart for as sess ing and im prov ing the transfer abil i ty of eco nom ic eval u a tion re sults be tween coun tries. Phar ma coeco nomics 22:857–876

  • R Welte, T Feen stra, H Jager, R Lei dl
  • Eur J Health Econom
  • 2004
2 Excerpts

Guide lines for com plet ing the EU RONHEED trans fer abil i ty check list. EU RON HEED working

  • S Boulenger, J Nixon, S Rice, P Ul mann, M Drum mond
  • 2004

Guide lines for com plet ing the EU RONHEED trans fer abil i ty check list

  • M Brown
  • 2004

De vel op ment and val i da tion of a grad ing sys tem for the qual i ty of cost-ef fective ness stud ies

  • CF Chiou
  • Med Care
  • 2003
1 Excerpt

Cost-ef fec tive ness anal ysis of ex emes tane com pared with mege strol in advanced breast can cer: a mod el for Eu rope and Australia

  • P Lind gren
  • Phar ma coeco nomics 20:101–108
  • 2002

Do de ci sion-mak ers find econom ic eval u a tions use ful? Re sults of re cent fo cus group re search in the UK

  • Hoff man
  • Health
  • 2002
1 Excerpt

How cost-ef fec tive is the treat ment of dys lipi demia in pa tients with di a betes but with out car dio vas cu lar dis ease? Di a be tes Care 24:45–50

  • S Grover
  • 2001

How costef fec tive is the treat ment of dys lipi demia in pa tients with di a betes but with out car dio vas cu lar dis ease ?

  • D Heaney
  • Di a be tes Care
  • 2001

Cost min i miza tion anal y sis of an ti epi lep tic drugs in new ly di ag nosed epi lep sy in 12 Eu ro pean coun tries. Epi lep sia 41:S37–S44

  • D Heaney
  • 2000
1 Excerpt

Similar Papers

Loading similar papers…